Sofroniew M V, Pearson R C. Degeneration of cholinergic neurons in the basal nucleus following kainic or N-methyl-D-aspartic acid application to the cerebral cortex in the rat[J]. Brain Res,1985,339(1):186.
[8]
Miyamoto M, Shintani M, Nagaoka A,et al. Lesioning of the rat basal forebrain leads to memory impairments in passive and active avoidance tasks[J]. Brain Res,1985,328(1):97.
[9]
Frautschy S A, Yang F, Calderon L, et al. Rodent models of Alzheimer\'s disease:rat Abata infusion approaches to amyloid deposits[J]. Neurobiol Aging,1996,17(2):311.
[10]
施新猷.现代医学实验动物学[M].北京:人民军医出版社,2000:332.
[11]
Malin D H, Crothers M K, LakeJ R, et al. Hippocampal injections of amyloid β-peptide 1-40 impair subsequent one-trial/day reward leaming[J]. Neurobio Leam Mern,2001,76(2):125.
[12]
Moir R D, Tanzi R E. LRP-mediated clearance of Abata is inhibited by KPI-containing is form of APP[J]. Curr Alzheimer Res, 2005,2(2):276.
Ok J, Martin L J. Rapid subcellular redistribution of Baxprecdes caspase-3 and endonuclear activation during excitoxic neuronal apoptosis in tar brain[J]. Neurotrauma,2002,19(7):815.
[15]
Glenner G G,Wong C W. Alzheimer\'s disease:initial report of the purification and characterization of a novel cerebrovascular amyloid protein[J].Biochem Biophys Res Commun,1984,120(3):885.
